Imatinib Completed Phase 3 Trials for CML, CML-CP,MMR,TKI Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02204644The Study of the Efficacy and the Safety of Flumatinib vs Imatinib as First Line Treatment in Patients With CML